Press Releases

LEXINGTON, Mass., July 18, 2019 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a broad pipeline of novel clinical and preclinical stage checkpoint antibodies, cell therapies and neoantigen vaccines, today announced the appointment of Don Vidic as Vice President, Head of Commercial.

Organic hemp farm infuses pure Certified Pharmaceutical Grade CBD containing Young Living essential oils and 0% THC. LEHI, Utah, July 18, 2019 /PRNewswire/ -- Young

SEATTLE, July 18, 2019 /PRNewswire/ -- From the microcosm to the telecosm to the cryptocosm, technology economist George Gilder has been at the leading edge of internet architecture for over 30 years. Now, along with Discovery Institute, he is convening the COSM Technology Summit to explore converging technologies as we move towards lif

LEXINGTON, Mass., July 18, 2019 /PRNewswire/ -- (Booth #1111) -- FUJIFILM Medical Systems U.S.A., Inc., a leadin

CONCORD, N.H., July 18, 2019 /PRNewswire/ -- Blueprint Recovery Center (www.blueprintrecoverycenter.com) has partnered with Next Level Church of

WASHINGTON, July 18, 2019 /PRNewswire/ -- Leaders from the American College of Surgeons (ACS) and Harvard Business School's (HBS) Institute for Strategy and Competitiveness gathered on Capitol Hill today to announce a new partnership aimed at improving health care value. The two organizations, recognized as global leaders in quality and cost

CHICAGO, July 18, 2019 /PRNewswire/ -- Seikagaku Corporation, a Japanese pharmaceutical and medical device company focused on providing innovative drug discovery specializing in glycoscience, will be featured at the Health & Fitness Expo during the Rock N' Roll Chicago Marathon Series on July 19­–20, 2019.  Over 1,600 runners and 25

Largest dealer in the upper Midwest will serve Minnesota and North Dakota BELOEIL, QC, July 18, 2019 /PRNewswire/ - 

NEW YORK, July 18, 2019 /PRNewswire/ -- Centinel Spine, LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced that it received Investigational Device Exemption (IDE) approval from the Food and Drug Administration (FDA) to initiate a two-level clinical trial with two different prodisc® C Anterior Cervical

WASHINGTON, July 18, 2019 /PRNewswire/ -- The National Association of Professional Insurance Agents (PIA National) praised the overwhelming passage in the U.S. House of a bipartisan bill to repeal the provision of the Affordable Care Act (ACA) known to many as the "Cadillac Tax." The Middle-Class Health Benefits Tax Repeal Act